SKI Market

A+| A| A-|

Indian Indices

Sensex

76,802.90 -607.08
( -0.78%)

Global Indices

Nasdaq

51,585.70 72.15
(0.14%)

Dow Jones

7,521.58 80.48
(1.08%)

Hang Seng

70,971.12 -82.37
(-0.12%)

Nikkei 225

10,357.71 -41.99
(-0.40%)

Forex

USD-INR

94.39 -0.12
(-0.13%)

EUR-INR

108.40 -1.03
(-0.94%)

GBP-INR

125.08 -1.43
(-1.13%)

JPY-INR

0.59 0.00
(-0.50%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Integrity Infrabuild Developers Ltd

Industry : Construction

BSE Code

ISIN Demat

Book Value()

94106

INE0YSH01017

63.7906977

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

INTEGRITY

10.19

70.26

EPS(TTM)

Face Value()

Div & Yield %

16.04

Back

Concord Biotech receives USFDA approval for Mycophenolate Mofetil for Oral Suspension USP

Jun 02,2026

Concord Biotech has received approval from the U.S. Food and Drug Administration (USFDA) for its ANDA for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL. Mycophenolate mofetil is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants.

76,802.90 -607.08 ( -0.78%)

51,585.70 72.15 (0.14%)

7,521.58 80.48 (1.08%)

70,971.12 -82.37 (-0.12%)

10,357.71 -41.99 (-0.40%)

94.39 -0.12 (-0.13%)

108.40 -1.03 (-0.94%)

125.08 -1.43 (-1.13%)

0.59 0.00 (-0.50%)